FORA Capital’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

FORA Capital’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-40,579	Closed	-$978K	–	675
2023 Q1	$978K	Buy	+40,579	New	+$509K	0.1%	250
2021 Q1	–	Sell	-7,444	Closed	-$126K	–	1206
2020 Q4	$126K	Buy	+7,444	New	+$112K	0.02%	615
2020 Q2	–	Sell	-3,463	Closed	-$32K	–	1401
2020 Q1	$32K	Buy	+3,463	New	+$44.6K	0.01%	876

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FORA Capital's PRVB Position: Q2 2023 in Review

FORA Capital sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 40,579 shares — an estimated $978K sold.

FORA Capital first reported a position in PRVB in Q1 2020 and held it in 3 quarters. The position peaked at $978K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

FORA Capital reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
FORA Capital sold 40,579 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $978K.
FORA Capital first reported a position in Provention Bio, Inc. Common Stock in Q1 2020 and held it in 3 quarters.
FORA Capital's Provention Bio, Inc. Common Stock position peaked at $978K in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on FORA Capital's 13F filing for Q2 2023, filed 11 Aug 2023.